Tekna - The Norwegian Society of Graduate Technical and Scientific Professionals Menu
Norsk | English
Search

BIOPROSP_19

Speakers

  • Anne-Belinda Bjerre

    Professor, PhD

    Danish Technological Institute (Denmark)

    Professor Anne-Belinda Bjerre is the scientific leader of the Biorefinery Group at DTI. During her 34 years research career at Risø National Laboratory (Risø DTU) and now at DTI, she has a long record in science of biomass conversion i.e. biorefinery of lignocellulose and seaweed to ethanol, butanol, biogas, and value-added products with an extensive record of publication, including 90 peer reviewed articles; more than 65 printed abstracts and proceedings; more than 100 conference presentation (posters and oral); 11 chapters in books and refereed research reports; 6 patents; H-factor 36; Citations 5,778 (updated August 2018). Anne-Belinda Bjerre has educated 12 PhD students, several post docs and guest scientists, masters and bachelor students during her career. Besides her job at DTI, Anne-Belinda is Adjunct professor at Aalborg University and she is Project Coordinator of large scale projects under Horizon 2020, BBI, Eranet, and Innovantionsfond Denmark with main focus, the last 7 years, on macro-algae research and demonstration.

    Catherine Boccadoro

    Research Director

    NORCE Norwegian Research Centre

    Catherine (Kate) Boccadoro is Research Director at NORCE and leads the Biotechnology research group in Stavanger, Norway. She holds a PhD in microbiology and biodegradation from the University of Cambridge. She develops and directs research projects in biodegradation, molecular microbial markers for the detection of pollutants in the marine environment, microbial populations and microbial production of biomass and chemicals through fermentation. She also leads the Norwegian Bioprocessing and Fermentation Centre (NBioC), a new research infrastructure focusing on bioprocess development, scale-up and piloting.

    Fayza Daboussi

    Research Director

    French National Institute for Agricultural Research (France)

    Fayza Daboussi, Research Director at the French National Institute for Agricultural Research (INRA). After 6 years in academic laboratories, she joined a biotechnology company, Cellectis, specialized in cancer immunotherapy and genome editing technologies. Over the 6 years spent in the Cellectis Company, she has developed strong scientific expertise in the genome engineering and synthetic biology fields in various model organisms. In 2012, she was given the responsibility of a key project stemming from a partnership between Total and Cellectis to develop microalgae-based oil substitutes. In 2015, she was appointed research director at the French National Institute for Agricultural Research to create a research group focused on the development of synthetic biology in microalgae within LISBP (Biosystems and Biochemical Engineering Laboratory). In 2018, she joins the scientific committee of the preindustrial demonstrator Toulouse White Biotechnologies.

    Dorothy Dankel

    Researcher

    The University of Bergen, Departement of Biological Sciences

    Dorothy Dankel is an interdisciplinary marine science researcher at the Department of Biological Sciences at the University of Bergen. Her background is in fisheries management with extended research stays at the Centre for the Study of the Sciences and Humanities at UiB, the International Institute of Applied Systems Analysis (IIASA) and the School of Marine Science and Technology at the University of Massachusetts, Dartmouth (SMAST). Dorothy is currently working on several projects as the Responsible Research and Innovation (RRI) researcher and coordinator on topics including gene-edited farmed salmon and systems toxicology of cod, in addition to university lectures on topics including the Sustainable Development Goals, bioethics and philosophy of science. She is also a board member of the Nordic Marine Think Tank (www.nmtt.org) and active in the International Council for the Exploration of the Sea's (ICES) strategic initiative to include human dimensions in marine science.

    Fernando de la Calle

    Head of Department

    PharmaMar (Spain)

    Dr Fernando de la Calle is currently the Head of the Microbiology Dpt. within Drug Discovery (R&D) at PharmaMar, biopharma involved in the development and commercialization of anticancer drugs of marine origin. He received his Ph.D. in Molecular Biology from UAM (Madrid) in 1998. He also completed an Executive-MBA at IDE-CESEM (Madrid) in 2005. He has more than 30 years’ experience working in drug discovery from marine microorganisms. He is an Expert in Applied Biotechnology, Molecular characterization of bacterial Biodiversity and the use of Biotechnology tools for Drug Discovery . Co-author of the current hemisynthetic process for manufacturing the anticancer Yondelis®, the first European marine derived compound approved. In addition, he has been external advisor for biotechnology issues to the Spanish Government (INCUAL), current member of the International Advisory Group of european ERA-NET for Marine Biotechnology and Biodiversity, reviewer for H2020 and ERA-NET projects and the scientific contact person from PharmaMar for FP7/H2020 EU projects related to Marine Biodiversity such as MAMBA, MaCuMBA, MicroB3 and INMARE as WP leader. Principal Investigator in more than 10 other nationally funded projects.

    Tom Ellis

    Reader in Synthetic Biology

    Imperial College London (UK)

    Dr Tom Ellis FRSC is a Reader in Synthetic Genome Engineering in the Bioengineering Department of Imperial College London with 50 publications in synthetic biology including work in Science, PNAS, Nature Methods & Nature Biotechnology. Dr Ellis is leading the UK’s effort in the world’s largest synthetic biology project: the Synthetic Yeast Genome (Sc2.0) project, and was recently appointed Associate Faculty in Synthetic Genomics by the Sanger Institute. His research focuses on design-led synthetic biology, developing genetic tools to better understand biology and program new functions including sensing, computation and biosynthesis. Dr Ellis holds a 5-year EPSRC Fellowship on synthetic biology, is on the editorial board for ACS Synthetic Biology and scientific advisory board of Addgene.org.

    Øyvind Eriksen

    Laboratory Manager

    Rise PFI AS

    Øyvind Eriksen has an MSc in chemical engineering and a PhD in paper physics from the Norwegian University of Science and Technology (NTNU). He started as a Research Scientist at RISE PFI in 2008, and has since 2013 been the Laboratory Manager at RISE PFI. His research has ranged from production of pulp and paper to production and applications of novel materials from lignocellulosic raw materials. Most of his research the last years have been in industry driven projects with a large implementation focus. Øyvind is the project manager of the Norwegian Biorefinery Laboratory (NorBioLab) infrastructure project.

    Hogne Hallaråker

    Founder and CSO

    Arctic Nutrition AS (Norway)

    Mr. Hallaråker is the founder and developer of a Phase IIb medicinal product for treating mild to moderate Psoriasis. He is an entrepreneur with more than 15 years of experience in Nutraceutical and Biomarine industries. His keen passion and knowledge within Natural sciences has resulted in a first-in-class pharmaceutical pipeline targeting auto-immune disease based entirely on extracts from Norwegian spring spawning herring. Mr Hallaråker has authored several scientific publications and patents covering composition, use and processing. He holds a M.Sc. degree in Marine Biology and Aquaculture from the University of Bergen. Former positions include CEO Arctic Nutrition, CEO Natural Nutrition Development, VP R&D Aker Biomarine, Product Director Natural ASA and Assistant Professor in Natural Science, Volda University College.

    Ralf Kellmann

    Scientific Leader

    The University of Bergen, Neosaxitoxin Research Consortium (Norway)

    Dr Ralf Kellmann is the scientific leader of the neosaxitoxin research consortium at the University of Bergen. He has obtained his MSc in 1999 at the Department of Marine Science, Otago University (New Zealand), and his PhD in 2005 at the School of Biotechnology and Biomolecular Sciences, University of NSW(Australia). His research focus is on the biosynthesis and genetics of microalgal toxins. Neosaxitoxin is a member of the paralytic shellfish toxin family and presently undergoing clinical trials as a novel pain medicine that can replace opioids in perioperative pain management. Industrial production of neosaxtoxin is challenging, however, as the natural producer organisms are difficult to culture, and chemical synthesis is exceedingly complex with low yields. Kellmann has previously discovered the biosynthesis genes for neosaxitoxin and its analogues, driven by the question, why phylogenetically divergent organisms, such as marine dinoflagellates and freshwater cyanobacteria can produce these complex and unique metabolites. The neosaxitoxin team is utilising the genetic knowledge in conjunction with tools from synthetic biology to develop a sustainable and economic industrial production process.

    Hordur Kristinsson

    Chief Science and Innovation Officer

    Matis (Iceland)

    Dr. Kristinsson is the Chief Science and Innovation Officer of Matis (English.matis.is), and is an Adjunct Associate Professor at the University of Florida and Courtesy Professor at the University of Iceland. He was previously an Associate Professor in Food Chemistry at the University of Florida. He has a PhD in Food Biochemistry, an MS degree in Food Science, an MBA and B.Sc. (hons.) in Molecular Biology. He combines over 20 years of practical experience of working in the food, biotech and functional ingredient industry with extensive commercial and research expertise in the production of various products and ingredients. He is the holder of six patents and has published over 110 peer-reviewed papers, book chapters and books. He has led numerous research and development projects funded by industry and competitive grant programs in the USA, Europe and Iceland, and currently manages several major national and international research and development projects. Dr. Kristinsson has worked with several major food companies as well as a large number of SMEs and entrepreneurs. Dr. Kristinsson has been directly involved in and founded several company start-ups in bioprocessing and functional ingredients. Dr. Kristinsson is the chair of the Nordic Bioeconomy Panel and was an appointed expert member of the first European Bioeconomy Panel from 2013-2015. Dr. Kristinsson also leads the activities of Matis in EIT Food (www.eitfood.eu), one of the largest food-related initiatives worldwide which aims for Europe to lead a global revolution in food innovation and production in the next seven years.

    Roger Linington

    Associate Professor

    Simon Fraser University (Canada)

    Professor Linington received his B.Sc. in Chemistry from the University of Leeds in the UK, his Ph.D. from the University of British Columbia in Vancouver Canada under the supervision of Prof. Raymond Andersen, and postdoctoral work with Prof. William Gerwick at the Scripps Institution of Oceanography at UCSD where he was a participating member of the Panama ICBG project. During this time he lived and worked in Panama City, Panama, running a semi-independent marine natural products drug discovery program. From 2007 to 2015 he was a faculty member at the University of California Santa Cruz in the Department of Chemistry and Biochemistry. Since 2015 he has been an Associate Professor of Chemistry at Simon Fraser University in Vancouver, Canada where he is also a Tier II Canada Research Chair in High-Throughput Screening and Chemical Biology. He is the recipient of several awards, including the 2014 American Society of Pharmacognosy Matt Suffness Young Investigator award. He has published 68 manuscripts, and his research program focuses on designing new screening and analytical methods for natural products discovery.

    Marianne Nymark

    Research Scientist

    NTNU Department of Biology (Norway)

    Marianne Nymark has a MSc in molecular biotechnology from the The Arctic University of Norway (UiT) and a PhD in biology from the Norwegian University of Science and Technology (NTNU). She has worked with marine diatoms since 2008, and is currently employed as a research scientist at the Cell, molecular biology and genomics group (CMBG) at NTNU, focusing on diatom functional genomics and strain improvement using the CRISPR/Cas9 technology. The CMBG group established the CRISPR/Cas9 technology for marine diatoms in 2016, and has further developed the technique to enable transgene-free genome editing.

    Håvard Sletta

    Research Manager

    SINTEF Biomass and Biomaterials (Norway)

    Håvard Sletta leads the Research group of Biotechnology (RGB) at SINTEF Industry. He has more than 25 years experience in development of bioprocesses in cooperation with industry. The RGB is currently involved several ongoing projects focusing on marine- and industrial biotechnology, strain engineering, synthetic- and systems biology, novel drugs, biopolymers and advanced biomaterials. The marine biorefinery part of this activity is focusing on development of tools and processes for processing of marine biomass, and development and application of marine biomass derived products. Sletta is leading several activities in this field, including national and international projects.

    Ragnhild Dragøy Whitaker

    Research Director

    Nofima

    Ragnhild Dragøy Whitaker is the director for the marine biotechnology group at Nofima. The group focuses on identifying, testing, isolating and scaling bioactive and valuable components, ingredients, peptides, molecules and composites from unused biomass. We mainly work with marine biomass and collaborate towards the terrestrial biomasses. The group develops processes in lab scale, and subsequently ensure that they are scalable and we can make prototype products at the demonstration facility, Biotep, which is owns and operated by Nofima. We work closely with consumer acceptance groups, with LCA and ensuing that the marine ingredients developed are sustainable and accepted in the market. Ragnhild holds a PhD in Chemistry and a MBA in sustainable innovation within the seafood sector. She has previously worked within bioprospecting and drug delivery before joining Nofima in 2014.

    Nadine Ziemert

    Professor

    University of Tübingen (Germany)

    Nadine Ziemert received her Diploma and PhD degrees from the Humboldt University in Berlin, followed by a postdoc and project scientist position at the Scripps Institution of Oceanography in La Jolla, California. Since 2015, she is a Professor at the University of Tübingen, where she leads an interdisciplinary research group focusing on genome mining approaches and the evolution of secondary metabolites in bacteria and their diverse functions.

    Margareth Øverland

    Professor

    NMBU, Faculty of Biosciences (Norway)

    Margareth Øverland has a BSc and MSc in animal nutrition from Montana State University in Montana USA and a PhD in animal nutrition from the Norwegian University of Life Sciences (NMBU). Today, she is a professor in nutrition at NMBU and she is the Center Director of a Center for Research-based Innovation (CRI), Foods of Norway. Margareths' research focus is to develop high-quality novel feed ingredients based on renewable natural resources such as tree biomass, marine macroalgae, and animal and fish co-products by use of advanced biotechnology and biorefinery technology. The research also aims to improve feed efficiency by innovative feed-processing technology and by use of advanced genomic analysis to support genetic adaptation of fish and other farm animals to the novel feed ingredients.